Awareness and early detection of cutaneous melanoma: An analysis of factors related to delay in treatment

British Journal of Dermatology

Volumn 141, Issue 5, 1999, Pages 783-787

  Blum, A ^a   Brand, C U ^b   Ellwanger, U ^a   Schlagenhauff, B ^a   Stroebel, W ^a   Rassner, G ^a   Garbe, Claus ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Awareness; Cutaneous melanoma; Diagnosis; Early detection; Primary prevention; Treatment

Indexed keywords

ARTICLE; AWARENESS; CANCER DIAGNOSIS; DIAGNOSTIC ERROR; EARLY DIAGNOSIS; FEMALE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PATIENT EDUCATION; PHYSICIAN ATTITUDE; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK FACTOR; SELF EVALUATION; SUN EXPOSURE;

ADULT; DIAGNOSTIC ERRORS; FEMALE; GERMANY; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MELANOMA; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; RISK FACTORS; SKIN NEOPLASMS; TIME FACTORS;

EID: 0032753382     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1999.03196.x     Document Type: Article

References (39)

1. 1 Parkin DM, Muir CS, Whelan SL et al. eds. Cancer Incidence in Five Continents. International Agency of Research on Cancer Scientific Publication No. 120, Vol. VI. New York: Oxford University Press, 1992.
2. 2 Berwick M. Epidermiology: Current trends, risk factors and environmental concerns. In: Cutaneous melanoma, 3rd edn. (Balch MC, Houghton AN, Sober AJ, Soong SJ, eds). St Louis: Quality Medical Publishing, Inc., 1998;552-5.
3. 3 Armstrong BK, Kricker A. Cutaneous melanoma. Cancer Surv 1994; 19-20: 219-40.
4. 4 Koh HK. Cutaneous melanoma. N Engl J Med 1991; 325: 171-82.
5. 5 Rigel DS, Friedman RJ, Kopf AW. The incidence of malignant melanoma in the United States: issues as we approach the 21st century. J Am Acad Dermatol 1996; 34: 839-47.
6. 6 Devesa SS, Blot WJ, Stone BJ et al. Recent cancer trends in the United States. J Natl Cancer Inst 1995; 87: 175-82.
7. 7 Garbe C, Büttner P, Bertz J et al. Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients. Cancer 1995; 75: 2484-91.
8. 8 Balch CM, Soong SJ, Murad TM et al. A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III). J Clin Oncol 1983; 1: 126-34.
9. 9 Barth A, Wanek LA, Morton DL. Prognostic factors in 1,521 melanoma patients with distant metastases. J Am Coll Surg 1995; 181: 193-201.
10. 10 Marks R. Skin cancer control in the 1990s, from slip! slop! slap! to sun smart. Australas J Dermatol 1990; 31: 1-4.
11. 11 Marks R, Hill D, eds. The Public Health Approach to Melanoma Control. Prevention and Early Detection. Geneva: International Union Against Cancer, 1992.
12. 12 Burton RC. Analysis of public education and the implications with regard to nonprogressive thin melanomas. Curr Opin Oncol 1995; 7: 170-4.
13. 13 Theobald T, Marks R, Hill D, Dorevitch A. 'Goodbye sunshine': effects of a television program about melanoma on beliefs, behavior, and melanoma thickness. J Am Acad Dermatol 1991; 25: 717-23.
14. 14 Hill D, White V, Marks R et al. Melanoma prevention: behavioral and nonbehavioral factors in sunburn among an Australian urban population. Prev Med 1992; 21: 654-69.
15. 15 Hill D, White V, Marks R, Borland R. Changes in sun-related attitudes and behaviours, and reduced sunburn prevalence in a population at high risk of melanoma. Eur J Cancer Prev 1993; 2: 447-56.
16. 16 Streetly A, Markowe H. Changing trends in the epidemiology of malignant melanoma: gender differences and their implications for public health. Int J Epidemiol 1995; 24: 897-907.
17. 17 Reintgen D, Cruse CW, Wells K et al. The effectiveness of skin cancer screening and continuing medical education programs toward increasing the survival of patients with malignant melanoma. Surg Oncol 1992; 1: 379-84.
18. 18 Garbe C, Krüger S, Stadler R et al. Markers and relative risk in a German population for developing malignant melanoma. Int J Dermatol 1989; 28: 517-23.
19. 19 Garbe C, Büttner P, Weiss J et al. Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenler case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J Invest Dermatol 1994; 102: 695-9.
20. 20 Kraehn GM, Schartl M, Peter RU. Human malignant melanoma. A genetic disease? Cancer 1995; 75: 1228-37.
21. 21 Grob JJ, Gouvernet J. Aymar D et al. Count of benign melanocytic nevi as a major indicator of risk for nonfamilial nodular and superficial spreading melanoma. Cancer 1990; 66: 387-95.
22. 22 Holly EA, Kelly JW, Shpall SN, Chiu SH. Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol 1987; 17: 459-68.
23. 23 Harrison SL, Buettner PG, MacLennan R. Body-site distribution of melanocytic nevi in young Australian children. Arch Dermatol 1999; 135: 47-52.
24. 24 Grulich AE, Bataille V, Swerdlow AJ et al. Naevi and pigmentary characteristics as risk factors for melanoma in a high-risk population: a case-control study in New South Wales, Australia. Int J Cancer 1996; 67: 485-91.
25. 25 Fritschi L, McHenry P, Green A et al. Naevi in schoolchildren in Scotland and Australia. Br J Dermatol 1994; 130: 599-603.
26. 26 Ford D, Bliss JM, Swerdlow AJ et al. Risk of cutaneous melanoma associated with a family history of the disease. The International Melanoma Analysis Group (IMAGE). Int J Cancer 1995; 62: 377-81.
27. 27 Carey WP Jr, Thompson CJ, Synnestvedt M et al. Dysplastic nevi as a melanoma risk factor in patients with familial melanoma. Cancer 1994; 74: 3118-25.
28. 28 Bourke JF, Healsmith MF, Graham-Brown RA. Melanoma awareness and sun exposure in Leicester. Br J Dermatol 1995; 132: 251-6.
29. 29 MacKie RM, Hole D. Audit of public education campaign to encourage earlier detection of malignant melanoma. Br Med J 1992; 304: 1012-15.
30. 30 Dobes WL Jr Melanoma skin cancer screenings. A how-to approach. Cancer 1995; 75: 705-6.
31. 31 Herd RM, Cooper EJ, Hunter JA et al. Cutaneous malignant melanoma. Publicity, screening clinics and survival - the Edinburgh experience 1982-90. Br J Dermatol 1995; 132: 563-70.
32. 32 Koh HK, Norton LA, Geller AC et al. Evaluation of the American Academy of Dermatology's National Skin Cancer Early Detection and Screening Program. J Am Acad Dermatol 1996; 34: 971-8.
33. 33 Cassileth BR, Temoshok L, Frederick BE et al. Patient and physician delay in melanoma diagnosis. J Am Acad Dermatol 1988; 18: 591-8.
34. 34 Rampen FH, Rumke P, Hart AA. Patients' and doctors' delay in the diagnosis and treatment of cutaneous melanoma. Eur J Surg Oncol 1989; 15: 143-8.
35. 35 Koh HK, Miller DR, Geller AC et al. Who discovers melanoma? Patterns from a population-based survey. J Am Acad Dermatol 1992; 26: 914-19.
36. 36 Miller DR, Geller AC, Wyatt SW et al. Melanoma awareness and self-examination practices: results of a United States survey. J Am Acad Dermatol 1996; 34: 962-70.
37. 37 Temoshok L, DiClemente RJ, Sweet DM et al. Factors related to patient delay in seeking medical attention for cutaneous malignant melanoma. Cancer 1984; 54: 3048-53.
38. 38 Howell JB, Cockerell CJ. Melanoma self-examination day: melanoma Monday, May 1, 1995. J Am Acad Dermatol 1996; 34: 837-8.
39. 39 Stephanson A, From L, Cohen A, Tipping J. Family physicians' knowledge of malignant melanoma. J Am Acad Dermatol 1997; 37: 953-7.